Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Sept 2023 for Ambrx Biopharma Inc..
Filing timeline
BuySaleMargaret Dalesandro
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+86.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Margaret Dalesandro: trading record in brief
This profile gathers the share dealings of Margaret Dalesandro across 3 companies, led by Ambrx Biopharma Inc., ONCOSEC MEDICAL Inc and Seelos Therapeutics, Inc. In total, 4 filings cover trades dated from 23 August 2021 to 1 September 2023.
Every open-market trade on record is a purchase: 2 purchases worth €52k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.
Most recently, on 6 September 2023, the filings show a share grant in Ambrx Biopharma Inc. The clock since the last published purchase (27 May 2022) now reads 1,611 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Margaret Dalesandro
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
125,000 shares0Ordinary SharesSEC:0000950170-23-046801:0
35,000 shares@ €0.5581100.0% of flowCommon StockSEC:0001136261-22-000247:0
Canonical exit: 24 Aug 2022 (T+90)
20,000 shares@ US$1.89100.0% of flowCommon StockSEC:0001493152-21-021268:0
Canonical exit: 21 Nov 2021 (T+90)
3 of 3 declarations
